1448 related articles for article (PubMed ID: 25933027)
1. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
2. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
3. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
4. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
5. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
6. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract][Full Text] [Related]
8. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
Liu BL; Sun KX; Zong ZH; Chen S; Zhao Y
Oncotarget; 2016 Feb; 7(6):6649-64. PubMed ID: 26673619
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9.
Wang Q; Tang H; Yin S; Dong C
Oncol Rep; 2013 May; 29(5):2046-52. PubMed ID: 23446431
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
Zhang L; Li Z; Gai F; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
15. Role of the lncRNA ABHD11-AS
Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y
Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
17. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
[TBL] [Abstract][Full Text] [Related]
18. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
19. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
20. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.
Li N; Zhao X; Wang L; Zhang S; Cui M; He J
Tumour Biol; 2016 Jun; 37(6):7767-76. PubMed ID: 26695144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]